MesotheliomaCenter's

Mesothelioma-Line

Curated Journal Articles on Mesothelioma

Category Archives: Lung Cancer

Viroimmunotherapy of Thoracic Cancers

Biomedicines 2017 January [Link] Dash AS, Patel MR Abstract Thoracic cancers, including non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), and malignant pleural mesothelioma (MM), cause the highest rate of cancer mortality worldwide. Most of these deaths are as a result of NSCLC; however, prognoses for the other two diseases remain as some […]

Comments Off on Viroimmunotherapy of Thoracic Cancers

CAR T-cell therapy for lung cancer and malignant pleural mesothelioma

Translational Research [Epub ahead of print] [Link] Zeltsman M, Dozier J, McGee E, Ngai D, Adusumilli PS Abstract Immunotherapy is a promising field that harnesses the power of the immune system as a therapeutic agent for cancer treatment. Beneficial outcomes shown in patients with non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma (MPM) with […]

Comments Off on CAR T-cell therapy for lung cancer and malignant pleural mesothelioma

Successful lung-sparing resection of synchronous pleural mesothelioma and contralateral lung cancer

Surgical Case Reports [Epub May 8] [Link] Imanishi N, Nabe Y, Takenaka M, Chikaishi Y, Kuroda K, Noguchi 2, Yatera K, Tanaka F Abstract BACKGROUND: Malignant pleural mesothelioma (MPM) is an uncommon malignant tumor, and its synchronous occurrence with primary lung cancer is extremely rare. Here, we report the first surgical case of synchronous MPM […]

Comments Off on Successful lung-sparing resection of synchronous pleural mesothelioma and contralateral lung cancer

Pleural mesothelioma in doll manufacture: possible asbestos exposure.

La Medicinia del lavoro 2017 April [Link] Barbieri PG, Somigliana AB, Lombardi S, Festa R, Girelli R, Sarnico M Abstract BACKGROUND: The occurrence of malignant mesothelioma is almost always causally associated to asbestos exposure but, considering women occurrences, this association is often difficult to demonstrate and consequently the asbestos exposure is defined as ‘unknown’. OBJECTIVES: […]

Comments Off on Pleural mesothelioma in doll manufacture: possible asbestos exposure.

Phase 1 Dose-Escalation Study of Pegylated Arginine Deiminase, Cisplatin, and Pemetrexed in Patients With Argininosuccinate Synthetase 1-Deficient Thoracic Cancers.

Journal of Clinical Oncology 2017 April [Epub ahead of print] [Link] Beddowes E, Spicer J, Chan PY, Khadeir R, Corbacho JG, Repana D, Steele JP, Schmid P, Szyszko T, Cook G, Diaz M, Feng X, Johnston A, Thomson J, Sheaff M, Wu BW, Bomalaski J, Pacey S, Szlosarek PW Abstract Purpose Pegylated arginine deiminase (ADI-PEG […]

Comments Off on Phase 1 Dose-Escalation Study of Pegylated Arginine Deiminase, Cisplatin, and Pemetrexed in Patients With Argininosuccinate Synthetase 1-Deficient Thoracic Cancers.

Mesothelin promotes epithelial-to-mesenchymal transition and tumorigenicity of human lung cancer and mesothelioma cells

Molecular Cancer 2017 March [a href=”https://www.ncbi.nlm.nih.gov/pubmed/28288645″>Link] He X, Wang L, Riedel H, Wang K, Yang Y, Dinu CZ, Rojanasakul Y Abstract BACKGROUND: Lung cancer and pleural mesothelioma are two of the most deadly forms of cancer. The prognosis of lung cancer and mesothelioma is extremely poor due to limited treatment modalities and lack of understanding […]

Comments Off on Mesothelin promotes epithelial-to-mesenchymal transition and tumorigenicity of human lung cancer and mesothelioma cells

The Controlling Nutritional Status Score Is a Significant Independent Predictor of Poor Prognosis in Patients With Malignant Pleural Mesothelioma

Clinical Lung Cancer 2017 February [Epub ahead of print] [Link] Takamori S, Toyokawa G, Taguchi K, Edagawa M, Shimamatsu S, Toyozawa R, Nosaki K, Seto T, Hirai F, Yamaguchi M, Shoji F, Okamoto T, Takenoyama M, Ichinose Y Abstract NTRODUCTION: Malignant pleural mesothelioma (MPM) is a devastating neoplasm; however, some patients exhibit a good response […]

Comments Off on The Controlling Nutritional Status Score Is a Significant Independent Predictor of Poor Prognosis in Patients With Malignant Pleural Mesothelioma

HMGB1 targeting by ethyl pyruvate suppresses malignant phenotype of human mesothelioma

Oncotarget 2017 February 7 [Epub ahead of print] [Link] Pellegrini L, Xue J1 Larson D, Pastorino S, Jube S, Forest KH, Saad-Jube ZS, Napolitano A, Pagano I, Negi VS, Bianchi ME, Morris P, Pass HI, Gaudino G, Carbone M, Yang H Abstract Human malignant mesothelioma (MM) is an aggressive cancer linked to asbestos and erionite […]

Comments Off on HMGB1 targeting by ethyl pyruvate suppresses malignant phenotype of human mesothelioma

Validation of Progression-Free Survival as a Surrogate Endpoint for Overall Survival in Malignant Mesothelioma: Analysis of Cancer and Leukemia Group B and North Central Cancer Treatment Group (Alliance) Trials.

Oncologist 2017 February 10 [Epub ahead of print] [Link] Wang X1, Wang X, Hodgson L, George SL, Sargent DJ, Foster NR, Kishor Ganti A, Stinchcombe TE, Crawford J, Kratzke R, Adjei AA, Kindler HL, Vokes EE, Pang H Abstract PURPOSE: The aim of this study was to investigate whether progression-free survival (PFS) can be considered […]

Comments Off on Validation of Progression-Free Survival as a Surrogate Endpoint for Overall Survival in Malignant Mesothelioma: Analysis of Cancer and Leukemia Group B and North Central Cancer Treatment Group (Alliance) Trials.

Paclitaxel-releasing mesenchymal stromal cells inhibit in vitro proliferation of human mesothelioma cells.

Biomedicine & Pharmacotherapy 2017 January [Epub ahead of print] [Link] Petrella F, Coccè V, Masia C, Milani M, Salè E, Alessandri G, Parati 4, Sisto F, Pentimalli F, Brini AT, Pessina A, Spaggiari L Abstract INTRODUCTION: Malignant pleural mesothelioma (MPM) is a rare fatal asbestos-related malignancy originating in the mesothelial cells of the pleura. A […]

Comments Off on Paclitaxel-releasing mesenchymal stromal cells inhibit in vitro proliferation of human mesothelioma cells.